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Metabolic alkalosis in hospitalised 
COVID-19 patients: A window to the 
pathogenesis?
To the Editor: South Africa has documented >600 000 confirmed 
COVID-19 cases within the 6 months since notification of the first 
case.[1] During this influx of COVID-19 patients, we have observed an 
under-reported finding on the arterial blood gas of some hospitalised 
patients, namely metabolic alkalosis with or without hypoxaemia. 
No known causes of alkalosis were present in these patients, and as 
it was clinically associated with SARS-CoV-2 infection, the finding 
soon became known as the ‘COVID gas’ among frontline clinicians.
We conducted a prospective cohort study to determine the 
prevalence and significance of otherwise unexplained metabolic 
alkalosis in 255 consecutive patients admitted with suspected 
COVID-19. Standard bicarbonate (sHCO3) was used as a marker for 
the metabolic component.[2]
One hundred and fifty patients tested SARS-CoV-2-positive. The 
median sHCO3 was 26.7 (interquartile range (IQR) 23.95 - 29.2) 
mmol/L, 27.6 (IQR 25.2 - 29.4) mmol/L and 25.2 (IQR 22.1 - 28.1) 
mmol/L for the whole cohort, the SARS-CoV-2-positive group and 
the SARS-CoV-2-negative group, respectively. The median pH was 
7.46 (IQR 7.4 - 7.49), 7.47 (IQR 7.45 - 7.5) and 7.42 (IQR 7.34 - 7.47) 
for the respective groups. Metabolic alkalosis (sHCO3 ≥28 mmol/L 
and pH ≥7.45) was significantly more common in SARS-CoV-2-
positive than SARS-CoV-2-negative patients (60/150 (40%) v. 17/105 
(16%); p<0.001). The median potassium level was 4.0 (IQR 4.0 - 4.5) 
mmol/L and 5.0 (IQR 4.0 - 5.0) mmol/L in the SARS-CoV-2-positive 
and negative groups, respectively. Thirteen patients in the SARS-
CoV-2-positive group (9%) had hypokalaemia (<3.5 mmol/L) and 
8 had both hypokalaemia and metabolic alkalosis. Urine samples 
obtained from 4 of these patients all showed an increased potassium-
to-creatinine ratio, with a median of 3.1 mmol/mmol. The ‘COVID 
gas’ had moderate specificity (84%) but poor sensitivity (40%) for 
COVID-19 diagnosis. In the 143 COVID-19 patients with available 
outcomes, neither the presence nor the absence of metabolic alkalosis 
predicted survival.
We present this unusual observation to assess opinion regarding 
the consistency of this finding in other centres, and to gather opinion 
as to the potential causes and clinical significance of the pronounced 
metabolic alkalosis. We speculate that the metabolic alkalosis may 
be due to excess mineralocorticoid-like effects or hypokalaemia, 
either from renal or gastrointestinal losses.[3] Chen et al.[4] reported 
a 53% prevalence of hypokalaemia in COVID-19 patients. The 
renin-angiotensin system (RAS) effects are antagonised by actions of 
angiotensin-converting enzyme 2 (ACE2). SARS-CoV-2 binds and 
degrades ACE2, thereby potentially reducing its counter-regulatory 
effects.[5] Increased RAS activity with increased angiotensin II and 
aldosterone effects may therefore promote distal nephron sodium 
reabsorption and enhanced urinary potassium excretion. Our cohort 
predominantly had normal concentrations of serum potassium, 
probably because the acute nature of SARS-CoV-2 infection does not 
affect total body potassium stores significantly.
The unusual presence of metabolic alkalosis on admission in 
a significant number of patients admitted with COVID-19 is an 
unreported finding requiring multicentre investigation to unravel 
the pathophysiology of the disease, including the significance of the 
acid-base abnormalities we observed.
Jacques Rood
Department of Medicine, Tygerberg Hospital and Faculty of Medicine 
and Health Sciences, Stellenbosch University, Cape Town, South Africa
Razeen Davids
Division of Nephrology, Department of Medicine, Tygerberg Hospital 
and Faculty of Medicine and Health Sciences, Stellenbosch University, 
Cape Town, South Africa
Alwyn le Roux
Department of Medical Imaging and Clinical Oncology, Tygerberg 
Hospital and Faculty of Medicine and Health Sciences, Stellenbosch 
University, Cape Town, South Africa
Melissa du Plessis
Division of General Medicine, Department of Medicine, Tygerberg 
Hospital and Faculty of Medicine and Health Sciences, Stellenbosch 
University, Cape Town, South Africa
Arifa Parker
Divisions of Infectious Diseases and General Medicine, Department 
of Medicine, Tygerberg Hospital and Faculty of Medicine and Health 
Sciences, Stellenbosch University, Cape Town, South Africa
Brian W Allwood
Division of Pulmonology, Department of Medicine, Tygerberg Hospital 
and Faculty of Medicine and Health Sciences, Stellenbosch University, 
Cape Town, South Africa
Hans W Prozesky
Division of Infectious Diseases, Department of Medicine, Tygerberg 
Hospital and Faculty of Medicine and Health Sciences, Stellenbosch 
University, Cape Town, South Africa
Coenraad F N Koegelenberg
Division of Pulmonology, Department of Medicine, Tygerberg Hospital 
and Faculty of Medicine and Health Sciences, Stellenbosch University, 
Cape Town, South Africa
Jantjie J Taljaard
Division of Infectious Diseases, Department of Medicine, Tygerberg 
Hospital and Faculty of Medicine and Health Sciences, Stellenbosch 
University, Cape Town, South Africa
jjt@sun.ac.za
1. Johns Hopkins University. Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html 
(accessed 7 September 2020).
2. Wettstein R, Wilkins R. Interpretation of blood gases. In: Wilkins RL, Dexter JR, Heuer AJ, eds. 
Wilkins’ Clinical Assessment in Respiratory Care. St Louis: Mosby, 2010.
3. Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What 
do we know till now? Arab J Gastroenterol 2020;21(1):3-8. https://doi.org/10.1016/j.ajg.2020.03.002
4. Chen D, Li X, Song Q, Assessment of hypokalemia and clinical characteristics in patients with 
coronavirus disease 2019 in Wenzhou, China. JAMA Netw Open 2020;3(6):e2011122. https://doi.
org/10.1001/jamanetworkopen.2020.11122
5. Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the renin-angiotensin system (RAS): A spark that 
sets the forest alight? Med Hypotheses 2020;144:110231. https://doi.org/10.1016/j.mehy.2020.110231
S Afr Med J 2020;110(11):1060. https://doi.org/10.7196/SAMJ.2020.v110i11.15287
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
